Viewing Study NCT01260766


Ignite Creation Date: 2025-12-24 @ 4:36 PM
Ignite Modification Date: 2025-12-28 @ 2:05 AM
Study NCT ID: NCT01260766
Status: UNKNOWN
Last Update Posted: 2010-12-17
First Post: 2010-12-14
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Acne Treatment With Active Oplon's Patches - 15-18 Years Old
Sponsor: Oplon-Pure Science Ltd.
Organization:

Study Overview

Official Title: Phase II- Acne Treatment With Active Patches Which Contains Azelaic Acid, Citric Acid,Salicylic Acid and 2% Ascorbic Acid
Status: UNKNOWN
Status Verified Date: 2010-12
Last Known Status: NOT_YET_RECRUITING
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The purpose of this study was to demonstrate the effect of short treatment with active OPLON patches on Acne.
Detailed Description: Patients with Acne Vulgaris were treated overnight with active patches. Effect is observed at the end of the treatment and 24 hours later.

Study Oversight

Has Oversight DMC: True
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: